Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Life360, Inc. Director's Dealing 2021

Aug 2, 2021

30724_rns_2021-08-02_52743624-0662-46b7-bb50-1cf366ba4d1f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director John Philip Coghlan
Date of last notice 15 June 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Seraph Life360, LLC (“Fund”)
Mr Coghlan is an investor in Fund and is
not involved in the management of the
Fund
Date of change 30 July 2021 (PDT)
No. of securities held prior to change
79,300 Shares of Common Stock
(Shares)
(equivalent
to
231,333
CHESS Depositary Interests (CDIs))

255,229
Options
over
Shares
(Options)

2,330 Restricted Stock Units (RSUs)

15,715 CDIs held by Seraph Life360,
LLC
Class CDIs
Number acquired
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed 4,706 CDIs1
Value/Consideration
Note: If consideration is non‐cash, provide details and estimated
valuation
A$8.1519 per CDI
No. of securities held after change
79,300 Shares (equivalent to 237,900
CDIs)

255,229 Options

2,330 RSUs

11,009 CDIs held by Seraph Life360,
LLC
Nature of change
Example: on‐market trade, off‐market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy‐back
On‐market trade.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non‐cash, provide details
and an estimated valuation
N/A
Interest after change N/A

1 The Fund sold a total of 200,000 CDIs on 30 July 2021. Mr Coghlan has a 2.35294% interest in the Fund which amounts to 4,706 CDIs in respect of this sale transaction.

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
Yes
If so, was prior written clearance provided to allow the trade
to proceed during this period?
No. Mr Coghlan is a minor and
passive investor in the Fund,
with
a
2.35294%
interest.
Beyond being an investor, Mr
Coghlan is not involved in the
management of the Fund nor
any decision as to the sale of
Life360 or any other securities
held by the Fund.
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3